Domestic radon exposure is widespread, and estimates suggest that it is a major contributor to the national burden of lung cancer (1) . Currently, the best available data upon which to base a risk assessment of residential radon exposure are derived from mining studies (2) (3) (4) (5) (6) , detection of lung cancer attributable to radon will require large sample sizes and accurate exposure estimates, as well as sound research design. However, many of the studies published to date have been inadequate in one respect or another. Some have been ecologic in design rather than case-control (7-10); some have suffered from small sample sizes (11) (12) (13) , inadequate exposure assessment (14, 15) , or from relatively low and homogeneous exposure levels (16, 17) , and most have included smokers, which may have obscured the effect of radon. Critical summaries of published studies have been reported (18, 19) . There are approximately 20 current studies of domestic radon and lung cancer risk which include over 12,000 lung cancer cases and 19,000 referents (20) . While these studies may have corrected many of the deficiencies of the earlier studies, there remains a paucity of subjects who are not current or former smokers. Thus, results from these studies will primarily reflect the relationship between lung cancer and radon among smokers. However, depending on the underlying joint effect between radon and smoking, the efficiency of these investigations may be compromised. In fact, the ability of these studies to detect the effect of radon at risk levels with significant pub- (21) to restrict studies to lower-risk populations in order to "strengthen weaker associations."
Methods
Two case-control design options were explored and are compared here: 1) carrying out a study in a mixed population of smokers and nonsmokers, made up of approximately 40.4% current smokers, 31.1% former smokers, and 28.5% neversmokers, and 2) carrying out a study among never-smokers only. In the latter case, it would of course be necessary to include a screening stage in the fieldwork plan to determine the smoking status of potential subjects.
A series of computations were performed, given the two design options, to explore the implications of the aforementioned phenomenon on sample-size requirements and costs. A number of assumptions were made, as follows: 1) the U.S. Environmental Protection Agency National Residential Radon Survey (23) was used to create a hypothetical distribu- When estimating sample size, it is necessary to fix some level of excess risk as the detectable level of the effect to be examined. It is customary to use the relative risk as the parameter to be fixed. However, for the purpose of this analysis, it was considered more appropriate to use the attributable risk because the relative risk of a high prevalence exposure in the general population may not be as relevant as the overall public health impact of the exposure. For an exposure as prevalent as radon, even a very low relative risk can result in a high attributable risk. For example, at an Rv of 1.1 among those exposed to the top quartile of radon levels, there would be almost 7,000 annual U.S. lung cancer deaths. While the failure to detect a relative risk as low as 1.1 might seem acceptable for many occupational or environmental exposures, this would result in a significant undetected hazard in the case of radon. The following formula expresses the joint effect of smoking and radon:
Rw, =[R0 XR0]qX [RW +R Os -q tive_ where q = 0 represents an additive joint effect, and q = 1 represents a multiplicative joint effect (6) (the analogous formula with "f* substituted for "s" was used for the joint effect of radon and former smoking). Lubin et al. (26) . Given each set of the quantities specified above, expected distributions of radon exposures for cases and controls were generated and used to calculate sample size requirements to detect a radon effect, assuming 80% power, a 1:1 case-control ratio, and a two-tailed a = 0.05. These calculations are described in greater detail in the appendix. The computations were implemented using Microsoft Excel version 5.0 (Microsoft Corporation, Redmond, Washington).
Once the sample sizes were estimated, additional computations 
administration of a home survey, repeated telephone contacts during the year of measurement, collection of detectors from each home, along with an updated home survey, data entry, and project coordination. Table 2 lists the costs that were assumed for subjects in each of the two study designs under consideration. Costs are provided for both never-smokers and a mixed population of smokers and nonsmokers (in naturally occurring proportions).
Results
Under the assumptions listed in Methods, and assuming an additive joint-effect model with an attributable risk of 5000 annual lung cancer deaths per year, only 111 cases and controls would be required if never-smokers were studied. If a similar study were conducted in a mixed smoker and nonsmoker population, however, the sample size required would increase to 5651 cases and controls. If the underlying joint-effect model were not additive and the attributable risk were nonetheless fixed at 5000 annual cases, the sample-size requirement would remain constant at 5651 in the mixed population but would Institute], then the sample-size requirement would be 577 in a never-smoker study and 5651 in a mixed population study.
Assuming a purely additive model, Figure 3 presents the sample-size requirements as a function of the potency of radon as a carcinogen (expressed as a varying attributable risk) for both never-smokers and a mixed population. The analysis demonstrates that under the additive model, studying never-smokers would require up to two orders of magnitude fewer subjects than studying a mixed population, irrespective of the level of relative or attributable risk within the range of attributable risks studied (500 to 13,500 attributable cases per year). Figure 4 presents cost estimates for identifying subjects and assessing exposure in studies among never-smokers and the general population of lung cancer cases, based on the estimated sample-size requirements of Figure 2 . A considerable savings can be appreciated for studies restricted to never-smokers when the joint effect is submultiplicative. In fact, if the true joint effect is approximately 0.19, as suggested by the weighted average of the joint-effect parameters found in the mining studies (3), then the cost estimate for a study of never-smokers is approximately eight times lower than a comparable study of a mixed population of current smokers, former smokers, and never-smokers.
Discussion
A large number of studies have been undertaken to examine the relationship between domestic radon and lung cancer. Since the vast majority of lung cancer patients (typically 95%) are or were smokers, most of these studies are dominated by smokers. If the joint effect between radon and smoking is multiplicative or supramultiplicative, some of these studies would have sufficient power to detect reasonable relative risks of lung cancer due to radon. On the other hand, if the joint effect is closer to additive, then it is unlikely that any of the current studies would have adequate power to detect the effect at risk levels that would be of public health importance. This could inappropriately lead to the conclusion that residential radon does not pose a significant carcinogenic risk.
One solution to this dilemma may be to increase sample sizes with additional studies among smokers. However, given the high cost of exposure assessment for radon, it would be more cost effective to study a smaller cohort of never-smokers. This advantage appears to hold for most levels of joint effect below multiplicative, even though the cost of case ascertainment for never-smokers is high (it generally Joint effect parameter Figure 4 . Estimated cost of identifying subjects and assessing exposure for a case-control study, given 5000 annual U.S. lung cancer deaths attributed to radon.
requires screening 20 cases to identify one never-smoker). Depending upon the sample size required (based upon the underlying joint effect), the difference in cost between studying smokers compared with never-smokers could be considerable. It may be that meta-analysis could extract additional useful information about the effect of radon among never-smokers. However, even when existing case-control studies are pooled, the total number of never-smokers remains small. This factor, and the usual heterogeneity of data sources, may still preclude a definitive conclusion about radon and lung cancer from a meta-analysis.
Another alternative might be to oversample never-smokers using a randomized recruitment approach to probability matching on smoking status, as suggested by Weinberg and Sandler (27) . Such an approach would allow one to take advantage of the extra information the neversmokers would provide if an additive (or submultiplicative) joint effect holds. This extra information is reflected in the contrasting sample sizes of 111 for neversmokers versus 5651 for smokers. If a sample size between these two extremes could be afforded, including data on smokers collected in the same study might allow for assessment of interaction. However, such a study would have a sample-size requirement of greater than 111 for the neversmoker stratum, since either the main effect estimate would be diluted by a much smaller effect of radon among the smokers, or a multiple comparison adjustment would be indicated for the separate subgroup tests.
If there had been no previous investigations, then the case for studying neversmokers versus smokers would not be as clearcut. In fact, it may be argued that these Volume 103, Number 1, January 1995-9.J i E S1 strategies evaluate different hypotheses. While the smoker study would also be able to examine the hypothesis of joint effect of smoking and radon, the never-smoker study may have greater power to examine the main effect of radon alone. Further, a never-smoker study might provide an opportunity to simultaneously examine the effects of passive smoking, which could not be examined among smokers, since the effect would be overwhelmed by the much stronger effect of active smoking.
The current ongoing studies may be adequate to evaluate the risk of radon among smokers if the joint smoking-radon effect is close to multiplicative. However, if the true joint effect between smoking and radon is close to additive, it would be more cost-effective to study never-smokers. Although case ascertainment costs would be considerably higher in a never-smoker study, this would be more than offset by the reduced sample-size requirement, which would reduce exposure assessment costs. However, a joint effect close to additive would also imply that the public health burden of radon as a lung carcinogen, as measured by the number of attributable cases, is less than it would be if the true joint effect approaches a multiplicative or supramultiplicative model. In this sense, the need to detect the risk associated with radon may be greater if the multiplicative model were correct.
Nevertheless, under the additive model, radon could be responsible for a large number of annual lung cancer cases, which would be extremely difficult to detect with a study of smokers. As previously mentioned, under an additive model, even very low relative risk levels can result in considerable mortality due to the large population exposed to radon and the high overall lung cancer mortality rate.
The present evaluation of differential costs for studies using different strategies was predicated on several simplifying assumptions, and varying these assumptions could affect the conclusions. First, the actual costs of screening for neversmokers and performing other aspects of an investigation may vary depending on where the study is undertaken. The relative advantages of one strategy over another may be affected if relative costs were very different from those assumed in Table 2 (6) , areas with low mobility are preferred. Effort must be made to maximize yield and minimize missing data in the reconstruction of the residential histories and in the placement of radon detectors in homes. The most commonly recommended method for exposure assessment is the year-long alpha-track measurement (28) . However, such measurements examine only current exposure at fixed ambient locations in the home. A possible complementary method of exposure measurement might include the use of heirloom glass or porcelain objects as dosimeters, or measurements of lead-210 emissions made in vivo (29) . The relationship between these measurements and actual historic cumulative dose to the human respiratory epithelium is not well established.
In conclusion, given the lack of welldesigned studies restricted to never-smokers, such an investigation may be indicated to examine the hypothesis that radon poses a significant public health risk to both smokers and nonsmokers under a submultiplicative, additive, or nonlinear model of joint effect between radon and smoking.
computed, i.e.: 146,000/(146,000 -15,000) = 1.1145. Step 3: From the above relationships, the quantities Cr s Cr and Cr n may be computed.
Step 4: The quantities C , C f, and C are r~~s' r~f' r,n then used to impute the distributions of radon exposure levels for current smokers, former smokers, and never smokers. These are in turn used to compute power or sample size using the Lubin method (26).
The starting point for the exposure distributions is the recent EPA residential radon survey data (30) . The exposure levels were grouped into convenient intervals of varying widths. Cutpoints were 0, 0.0625, 0.125, . . . It is assumed that the rate of radon-induced lung cancer is linearly related to the exposure level. Therefore, the proportion of lung cancers in the ith interval is estimated to be:
CI/C= (Cr/C)(HI)(E.)/(SHlE,) +( -CQIC)(HI)I(SHi)
where Hi is the proportion of homes in the ith exposure interval. If C , Ct f and C; n are substituted for Cr, and Crs C, and C, f~or C, respectively, in the above formula, proportions of lung cancers at each exposure level for current, former, and never smokers may be estimated.
